EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $280,454 | -55.4% | 17,784 | -45.1% | 0.00% | -50.0% |
| Q2 2023 | $629,389 | -22.7% | 32,376 | +12.8% | 0.00% | -50.0% |
| Q1 2023 | $814,474 | -14.1% | 28,709 | -11.5% | 0.00% | -20.0% |
| Q4 2022 | $947,958 | -6.4% | 32,431 | -15.4% | 0.01% | -16.7% |
| Q3 2022 | $1,013,000 | +186.2% | 38,330 | +435.5% | 0.01% | +100.0% |
| Q1 2022 | $354,000 | -29.1% | 7,158 | -26.9% | 0.00% | -25.0% |
| Q4 2021 | $499,000 | +77.6% | 9,793 | +45.5% | 0.00% | 0.0% |
| Q1 2021 | $281,000 | +9.3% | 6,729 | +21.9% | 0.00% | 0.0% |
| Q4 2020 | $257,000 | – | 5,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |